Nitric oxide (NO) plays important, but incompletely defined roles in skeletal muscle. NO exerts its regulatory effects partly though S-nitrosylation, which is balanced by denitrosylation by enzymes such as S-nitrosoglutathione reductase (GSNOR), whose functions in skeletal muscle remain to be fully deciphered.
Results:
GSNOR null (GSNOR−/−) tibialis anterior (TA) muscles showed normal growth and were stronger and more fatigue resistant than controls in situ. However, GSNOR−/− lumbrical muscles showed normal contractility and Ca2+ handling in vitro, suggesting important differences in GSNOR function between muscles or between in vitro and in situ environments. GSNOR−/− TA muscles exhibited normal mitochondrial content, and capillary densities, but reduced type IIA fiber content. GSNOR inhibition did not impact mitochondrial respiratory complex I, III, or IV activities. These findings argue that enhanced GSNOR−/− TA contractility is not driven by changes in mitochondrial content or activity, fiber type, or blood vessel density. However, loss of GSNOR led to RyR1 hypernitrosylation, which is believed to increase muscle force output under physiological conditions. cGMP synthesis by soluble guanylate cyclase (sGC) was decreased in resting GSNOR−/− muscle and was more responsive to agonist (DETANO, BAY 41, and BAY 58) stimulation, suggesting that GSNOR modulates cGMP production in skeletal muscle.
Innovation:
GSNOR may act as a “brake” on skeletal muscle contractile performance under physiological conditions by modulating nitrosylation/denitrosylation balance.
Conclusions:
GSNOR may play important roles in skeletal muscle contractility, RyR1 S-nitrosylation, fiber type specification, and sGC activity. Antioxid. Redox Signal. 26, 165–181.
Get full access to this article
View all access options for this article.
References
1.
AdamoCM, DaiDF, PercivalJM, MinamiE, WillisMS, PatruccoE, FroehnerSC, and BeavoJA. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A, 107: 19079–19083, 2010.
AnderssonDC, BetzenhauserMJ, ReikenS, MeliAC, UmanskayaA, XieW, ShiomiT, ZalkR, LacampagneA, and MarksAR. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab, 14: 196–207, 2011.
4.
AnderssonDC, MeliAC, ReikenS, BetzenhauserMJ, UmanskayaA, ShiomiT, D'ArmientoJ, and MarksAR. Leaky ryanodine receptors in beta-sarcoglycan deficient mice: a potential common defect in muscular dystrophy. Skelet Muscle, 2: 9, 2012.
5.
AracenaP, SanchezG, DonosoP, HamiltonSL, and HidalgoC. S-glutathionylation decreases Mg2+ inhibition and S-nitrosylation enhances Ca2+ activation of RyR1 channels. J Biol Chem, 278: 42927–42935, 2003.
6.
BaumO, ViereggeM, KochP, GulS, HahnS, Huber-AbelFA, PriesAR, and HoppelerH. Phenotype of capillaries in skeletal muscle of nNOS-knockout mice. Am J Physiol Regul Integr Comp Physiol, 304: R1175–R1182, 2013.
7.
BeigiF, GonzalezDR, MinhasKM, SunQA, FosterMW, KhanSA, TreuerAV, DulceRA, HarrisonRW, SaraivaRM, PremerC, SchulmanIH, StamlerJS, and HareJM. Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. Proc Natl Acad Sci U S A. 109: 4314–4319, 2012.
8.
BellingerAM, ReikenS, CarlsonC, MongilloM, LiuX, RothmanL, MateckiS, LacampagneA, and MarksAR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med, 15: 325–330, 2009.
9.
BellingerAM, ReikenS, DuraM, MurphyPW, DengSX, LandryDW, NiemanD, LehnartSE, SamaruM, LaCampagneA, and MarksAR. Remodeling of ryanodine receptor complex causes “leaky” channels: a molecular mechanism for decreased exercise capacity. Proc Natl Acad Sci U S A, 105: 2198–2202, 2008.
10.
BodineSC and BaehrLM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab, 307: E469–E484, 2014.
11.
BriguetA, Courdier-FruhI, FosterM, MeierT, and MagyarJP. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul Disord, 14: 675–682, 2004.
12.
BrownGC and CooperCE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett, 356: 295–298, 1994.
13.
BustinSA, BenesV, GarsonJA, HellemansJ, HuggettJ, KubistaM, MuellerR, NolanT, PfafflMW, ShipleyGL, VandesompeleJ, and WittwerCT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem, 55: 611–622, 2009.
14.
BuysES, SipsP, VermeerschP, RaherMJ, RoggeE, IchinoseF, DewerchinM, BlochKD, JanssensS, and BrouckaertP. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice. Cardiovasc Res, 79: 179–186, 2008.
15.
CaoY, GomesSA, RangelEB, PaulinoEC, FonsecaTL, LiJ, TeixeiraMB, GouveiaCH, BiancoAC, KapiloffMS, BalkanW, and HareJM. S-nitrosoglutathione reductase-dependent PPARgamma denitrosylation participates in MSC-derived adipogenesis and osteogenesis. J Clin Invest, 125: 1679–1691, 2015.
16.
ChurchJE, GehrigSM, CheeA, NaimT, TrieuJ, McConellGK, and LynchGS. Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence. Am J Physiol Regul Integr Comp Physiol, 301: R1358–R1366, 2011.
17.
CleeterMW, CooperJM, Darley-UsmarVM, MoncadaS, and SchapiraAH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett, 345: 50–54, 1994.
18.
ClementiE, BrownGC, FeelischM, and MoncadaS. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A, 95: 7631–7636, 1998.
19.
ConleyKE, JubriasSA, AmaraCE, and MarcinekDJ. Mitochondrial dysfunction: impact on exercise performance and cellular aging. Exerc Sport Sci Rev, 35: 43–49, 2007.
20.
De PalmaC, MorisiF, PambiancoS, AssiE, TouvierT, RussoS, PerrottaC, RomanelloV, CarnioS, CappelloV, PellegrinoP, MoscheniC, BassiMT, SandriM, CerviaD, and ClementiE. Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation. Skelet Muscle, 4: 22, 2014.
21.
DerbyshireER and MarlettaMA. Structure and regulation of soluble guanylate cyclase. Annu Rev Biochem, 81: 533–559, 2012.
22.
DurhamWJ, Aracena-ParksP, LongC, RossiAE, GoonasekeraSA, BoncompagniS, GalvanDL, GilmanCP, BakerMR, ShirokovaN, ProtasiF, DirksenR, and HamiltonSL. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell, 133: 53–65, 2008.
23.
DutkaTL, MollicaJP, PosterinoGS, and LambGD. Modulation of contractile apparatus Ca2+ sensitivity and disruption of excitation-contraction coupling by S-nitrosoglutathione in rat muscle fibres. J Physiol, 589: 2181–2196, 2011.
24.
EuJP, HareJM, HessDT, SkafM, SunJ, Cardenas-NavinaI, SunQA, DewhirstM, MeissnerG, and StamlerJS. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A, 100: 15229–15234, 2003.
25.
EuJP, SunJ, XuL, StamlerJS, and MeissnerG. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell, 102: 499–509, 2000.
26.
ForresterMT, ThompsonJW, FosterMW, NogueiraL, MoseleyMA, and StamlerJS. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol, 27: 557–559, 2009.
27.
FosterMW, HessDT, and StamlerJS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med, 15: 391–404, 2009.
28.
FosterMW and StamlerJS. New insights into protein S-nitrosylation. Mitochondria as a model system. J Biol Chem, 279: 25891–25897, 2004.
29.
FriebeA and KoeslingD. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide, 21: 149–156, 2009.
30.
FroehnerSC, ReedSM, AndersonKN, HuangPL, and PercivalJM. Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. Hum Mol Genet, 24: 492–505, 2015.
31.
GalkinA and MoncadaS. S-nitrosation of mitochondrial complex I depends on its structural conformation. J Biol Chem, 282: 37448–37453, 2007.
32.
GentilC, LeturcqF, Ben YaouR, KaplanJC, LaforetP, Penisson-BesnierI, Espil-TarisC, VoitT, GarciaL, and Pietri-RouxelF. Variable phenotype of del45-55 Becker patients correlated with nNOSmu mislocalization and RYR1 hypernitrosylation. Hum Mol Genet, 21: 3449–3460, 2012.
33.
GouldN, DouliasPT, TenopoulouM, RajuK, and IschiropoulosH. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem, 288: 26473–26479, 2013.
34.
HaldarSM and StamlerJS. S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. J Clin Invest, 123: 101–110, 2013.
35.
HessDT and StamlerJS. Regulation by S-nitrosylation of protein post-translational modification. J Biol Chem, 287: 4411–4418, 2012.
36.
Hinchee-RodriguezK, GargN, VenkatakrishnanP, RomanMG, AdamoML, MastersBS, and RomanLJ. Neuronal nitric oxide synthase is phosphorylated in response to insulin stimulation in skeletal muscle. Biochem Biophys Res Commun, 435: 501–505, 2013.
37.
HongYH, FrugierT, ZhangX, MurphyRM, LynchGS, BetikAC, RattiganS, and McConellGK. Glucose uptake during contraction in isolated skeletal muscles from neuronal nitric oxide synthase mu knockout mice. J Appl Physiol (1985), 118: 1113–1121, 2015.
38.
IglesiasDE, BombicinoSS, ValdezLB, and BoverisA. Nitric oxide interacts with mitochondrial complex III producing antimycin-like effects. Free Radic Biol Med, 89: 602–613, 2015.
39.
KobzikL, ReidMB, BredtDS, and StamlerJS. Nitric oxide in skeletal muscle. Nature, 372: 546–548, 1994.
40.
LiD, YueY, LaiY, HakimCH, and DuanD. Nitrosative stress elicited by nNOSmicro delocalization inhibits muscle force in dystrophin-null mice. J Pathol, 223: 88–98, 2011.
41.
LimaB, LamGK, XieL, DiesenDL, VillamizarN, NienaberJ, MessinaE, BowlesD, KontosCD, HareJM, StamlerJS, and RockmanHA. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci U S A, 106: 6297–6302, 2009.
42.
LiuL, YanY, ZengM, ZhangJ, HanesMA, AhearnG, McMahonTJ, DickfeldT, MarshallHE, QueLG, and StamlerJS. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell, 116: 617–628, 2004.
43.
LivakKJ and SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25: 402–408, 2001.
44.
MontagnaC, Di GiacomoG, RizzaS, CardaciS, FerraroE, GrumatiP, De ZioD, MaianiE, MuscoliC, LauroF, IlariS, BernardiniS, CannataS, GargioliC, CirioloMR, CecconiF, BonaldoP, and FilomeniG. S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction. Antioxid Redox Signal, 21: 570–587, 2014.
45.
NisoliE, ClementiE, PaolucciC, CozziV, TonelloC, ScioratiC, BracaleR, ValerioA, FrancoliniM, MoncadaS, and CarrubaMO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science, 299: 896–899, 2003.
46.
NisoliE, FalconeS, TonelloC, CozziV, PalombaL, FioraniM, PiscontiA, BrunelliS, CardileA, FrancoliniM, CantoniO, CarrubaMO, MoncadaS, and ClementiE. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A, 101: 16507–16512, 2004.
47.
PercivalJM. nNOS regulation of skeletal muscle fatigue and exercise performance. Biophys Rev, 3: 209–217, 2011.
48.
PercivalJM, AdamoCM, BeavoJA, and FroehnerSC. Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. Handb Exp Pharmacol, 204: 323–344, 2011.
49.
PercivalJM, AndersonKN, GregorevicP, ChamberlainJS, and FroehnerSC. Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One, 3: e3387, 2008.
50.
PercivalJM, AndersonKN, HuangP, AdamsME, and FroehnerSC. Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J Clin Invest, 120: 816–826, 2010.
51.
PercivalJM, WhiteheadNP, AdamsME, AdamoCM, BeavoJA, and FroehnerSC. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol, 228: 77–87, 2012.
52.
PiantadosiCA and SulimanHB. Redox regulation of mitochondrial biogenesis. Free Radic Biol Med, 53: 2043–2053, 2012.
53.
RameauGA, TukeyDS, Garcin-HosfieldED, TitcombeRF, MisraC, KhatriL, GetzoffED, and ZiffEB. Biphasic coupling of neuronal nitric oxide synthase phosphorylation to the NMDA receptor regulates AMPA receptor trafficking and neuronal cell death. J Neurosci, 27: 3445–3455, 2007.
54.
SayedN, BaskaranP, MaX, van den AkkerF, and BeuveA. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci U S A, 104: 12312–12317, 2007.
55.
SayedN, KimDD, FioramontiX, IwahashiT, DuranWN, and BeuveA. Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res, 103: 606–614, 2008.
56.
SchneiderCA, RasbandWS, and EliceiriKW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods, 9: 671–675, 2012.
57.
ShankarRR, WuY, ShenHQ, ZhuJS, and BaronAD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes, 49: 684–687, 2000.
58.
ShivaS, SackMN, GreerJJ, DuranskiM, RingwoodLA, BurwellL, WangX, MacArthurPH, ShojaA, RaghavachariN, CalvertJW, BrookesPS, LeferDJ, and GladwinMT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med, 204: 2089–2102, 2007.
59.
SilvagnoF, XiaH, and BredtDS. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem, 271: 11204–11208, 1996.
60.
StoyanovskyD, MurphyT, AnnoPR, KimYM, and SalamaG. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium, 21: 19–29, 1997.
61.
SunJ, XinC, EuJP, StamlerJS, and MeissnerG. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci U S A, 98: 11158–11162, 2001.
62.
SunJ, XuL, EuJP, StamlerJS, and MeissnerG. Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel. J Biol Chem, 278: 8184–8189, 2003.
63.
SunQA, WangB, MiyagiM, HessDT, and StamlerJS. Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor/Ca2+ release channel (RyR1): sites and nature of oxidative modification. J Biol Chem, 288: 22961–22971, 2013.
64.
SuzukiN, MotohashiN, UezumiA, FukadaS, YoshimuraT, ItoyamaY, AokiM, Miyagoe-SuzukiY, and TakedaS. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest, 117: 2468–2476, 2007.
65.
ThomasGD, ShaulPW, YuhannaIS, FroehnerSC, and AdamsME. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase. Circ Res, 92: 554–560, 2003.
66.
TsikasD. Potential problems and pitfalls with the use of S-nitrosoglutathione and other S-nitrosothiols in physiology-oriented basic science. J Physiol, 590: 6247–6248, 2012.
67.
WangY and KerrickWG. The off rate of Ca(2+) from troponin C is regulated by force-generating cross bridges in skeletal muscle. J Appl Physiol (1985), 92: 2409–2418, 2002.
68.
YamadaT, FedotovskayaO, ChengAJ, CornachioneAS, MinozzoFC, AulinC, FridenC, TuressonC, AnderssonDC, GlenmarkB, LundbergIE, RassierDE, WesterbladH, and LannerJT. Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness. Ann Rheum Dis, 74: 1907–1914, 2015.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
